FORMA THERAPEUTICS HOLDINGS (FMTX) Stock Analyst Earnings Estimates
NASDAQ:FMTX - Nasdaq - US34633R1041 - Common Stock - Currency: USD
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | ||
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 164.1M | 100.6M -38.70% | 170.003K -100.00% | 1.02M | 15.494M 1,419.04% | 3.498M -77.42% | 8.574M 145.10% | 21.435M 150.00% | ||
| EBITDA YoY % growth | 13.23M | -32.53M -345.88% | -130.278M -277.56% | -178.112M -40.38% | -217.788M -26.31% | -220.971M -1.46% | -266.454M -20.58% | -232.436M 12.77% | -206.816M 11.02% | |
| EBIT YoY % growth | 9.7M | -35.2M -462.89% | -129.366M -252.56% | -173.15M -40.20% | -209.602M -20.47% | -222.411M -6.11% | -278.664M -25.29% | -230.303M 17.35% | -194.142M 15.70% | |
| Operating Margin | 5.91% | -34.99% | -76,095.88% | N/A | -20,549.23% | -1,435.45% | -7,965.94% | -2,686.06% | -905.72% | |
| EPS YoY % growth | N/A | N/A | -3.72 | -3.63 1.80% | -4.35 -19.14% | -3.68 15.44% | -3.87 -5.13% | -3.99 -3.09% | -4.19 -5.15% |
All data in USD
| Q3 / 22 | Q4 / 22 | Q1 / 23 | Q2 / 23 | Q3 / 23 | Q4 / 23 | |
|---|---|---|---|---|---|---|
| EPS Q2Q % growth | -1.10 -20.83% | -1.13 -6.81% | -0.90 2.94% | -1.07 2.64% | -1.12 -2.04% | -1.14 -0.45% |
| Revenue Q2Q % growth | 1.285M | 469.2K | 11.73M | 4.227M | 183.6K -85.71% | 257.04K -45.22% |
| EBITDA Q2Q % growth | -54.207M -26.77% | -61.816M -26.89% | N/A | N/A | N/A | N/A |
| EBIT Q2Q % growth | -52.995M -22.02% | -54.863M -9.10% | -43.372M 2.34% | -51.65M 2.54% | -56.669M -6.93% | -57.069M -4.02% |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q2 2022 Q2Q % growth | -1.10 -19.57% | -1.01 | -0.09 | -9.37% |
| Q1 2022 Q2Q % growth | -0.93 -22.37% | -1.08 | 0.15 | 13.49% |
| Q4 2021 Q2Q % growth | -1.06 -55.88% | -0.98 | -0.08 | -7.71% |
| Q3 2021 Q2Q % growth | -0.91 -35.82% | -0.98 | 0.07 | 7.19% |
| Q2 2021 Q2Q % growth | -0.92 79.91% | -0.81 | -0.11 | -13.78% |
| Q1 2021 Q2Q % growth | -0.76 | -0.78 | 0.02 | 2.60% |
| Q4 2020 Q2Q % growth | -0.68 | -0.82 | 0.14 | 16.61% |
| Q3 2020 Q2Q % growth | -0.67 | -0.69 | 0.02 | 3.05% |
| Q2 2020 Q2Q % growth | -4.58 | -0.75 | -3.83 | -509.53% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q4 2020 Q2Q % growth | 204K | -204K | -100.00% | |
| Q3 2020 Q2Q % growth | 510K | -510K | -100.00% | |
| Q2 2020 Q2Q % growth | -100.00% | 510K | -510K | -100.00% |
| Q1 2020 Q2Q % growth | -100.00% | % |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | N/A | N/A | N/A | N/A |
| Revenue | N/A | N/A | N/A | N/A |